Skip to main content
. 2020 Nov 10;20:293. doi: 10.1186/s12890-020-01331-3

Table 3.

Changes in bronchiectasis severity index of 31 patients between the time of entry into the non-NTM bronchiectasis cohort and the time at the diagnosis of NTM-PD

n = 31 Entry of non-NTM BE cohort Diagnosis of NTM-PD P-value
Age, years 0.126
  < 50 7 (22.6) 2 (6.5)
 50–69 22 (71.0) 24 (77.4)
 70–79 2 (6.5) 5 (16.1)
  < 80 0 0
Body mass index, kg/m2 0.782
  < 18.5 4 (12.9) 4 (12.9)
 18.5–25 23 (74.2) 21 (67.7)
 26–29 4 (12.9) 6 (19.4)
 30 or more 0 0
FEV1, % predicted 0.570
  > 80 21 (67.7) 24 (77.4)
 50–80 10 (32.3) 7 (22.6)
 30–49 0 0
  < 30 0 0
Hospital admission during the last 2 years 0.554
 No 22 (71.0) 25 (80.9)
 Yes 9 (29.0) 6 (19.4)
Exacerbation during the last 1 year 0.317
 0 22 (71.0) 19 (61.3)
 1–2 2 (6.4) 6 (19.4)
 3 or more 7 (22.6) 6 (19.4)
MRC dyspnea score > 0.999
 1–3 31 (100.0) 31 (100.0)
 4 0 0
 5 0 0
Pseudomonas colonization > 0.999
 No 31 (100.0) 31 (100.0)
 Yes 0 0
Colonization with other organisms > 0.999
 No 29 (93.5) 29 (93.5)
 Yes 2 (6.5) 2 (6.5)
3 or more lobes involved or cystic bronchiectasis 0.434
 No 14 (45.2) 10 (31.4)
 Yes 17 (54.8) 21 (67.7)
Bronchiectasis severity score 0.491
 Mild 21 (67.7) 17 (54.8)
 Moderate 6 (19.4) 10 (32.3)
 Severe 4 (12.9) 4 (12.9)
Total score, median [IQR] 4 [2, 7] 4 [3, 6] 0.903

BE bronchiectasis, NTM-PD nontuberculous mycobacterial pulmonary disease, IQR inter-quartile range